Patients, families and communities affected by rare disease experience significant mental health challenges. Over the past decade, many rare communities, supported by industry partners, have expanded their support programming to include mental health needs. This workshop will focus on the unique mental health needs of rare communities and will provide examples of practical support programs designed to meet these needs.
Objectives:
Mental health is a critical—but often underdeveloped—component of rare disease care, despite growing recognition of its impact on patients, caregivers, and clinical trial participation. This panel brings together psychologists and patient advocates to help industry leaders understand why mental health must be integrated into rare disease programs and how to do so in a practical, phased way. Through real-world examples, speakers will outline where industry can start, how to prioritize investments, and how to design mental health support that is meaningful, scalable, and aligned with patient needs across programs and clinical trials.
Objectives: